Skip to content

Establishment of a multi-center clinical pathology database for cervical cancer in Shanxi Province

Establishment of a multi-center clinical pathology database for cervical cancer in Shanxi Province

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033137
Enrollment
Unknown
Registered
2020-05-22
Start date
2005-01-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Cervical cancer case group:none

Sponsors

The Second Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: In the past 10 years (2005-2014), 14 hospitals in 5 districts of Taiyuan, Datong, Yuncheng, Changzhi and Jincheng in Shanxi Province were treated with IA1-IVA cases of cervical cancer treated with surgery. The case data is complete.

Exclusion criteria

Exclusion criteria: The results of cervical biopsy pathological consultation were CIN and other non-cervical cancer cases; the treatment process was interrupted, such as surgery after neoadjuvant chemotherapy; postoperative pathological results were non-cervical malignant tumors; combined with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Nationality;Age;place of origin;occupation;education level;economic condition;height;weight;contact information;Menstrual history;marriage history;maternal history;history of sexually transmitted diseases;TCT;colposcopy;biopsy pathology;CA125;SCC;HPV;other tumor markers;HPV type;gross type;tumor size;FIGO stage;B-ultrasound;CT;MRI;PET-CT;Preoperative adjuvant therapy;Preoperative adjuvant therapy time;Preoperative adjuvant therapy dose;Preoperative adjuvant therapy effect;operation time;Anesthesia;Time of surgery;Operator;Surgical approach;Piver classification;Resection of lymph node type;Resection of lymph node type;Resection of lymph node type;Resection of lymph node type;Resection of lymph node type;Preoperative Hb;Amount of bleeding;Blood transfusion;complication;Tissue type;tissue grade;cervical length/thickness;cervical infiltration;uterine infiltration;nerve infiltration;LVSI;Left main ligament;right main ligament;left uterine ligament;right uterine ligament;left cervix vaginal ligament;right bladder cervicovaginal ligament;Left uterus;right uterus;vaginal margin;vaginal fornix;ovarian metastasis;fallopian tube metastasis;immunohistochemistry;Left pelvic lymph node resection;left pelvic lymph node metastasis;left common iliac lymph node;left lateral iliac lymph node;left lateral iliac lymph node;Left axillary lymph node;left inguinal deep lymph node;left obturator upper lymph node;left closed lymph node;left closed obturator lymph node;left obturator deep lymph node;Right pelvic lymph node resection;right pelvic lymph node metastasis;right common iliac lymph node;right lateral iliac lymph node;right lateral iliac lymph node;Right intraorbital lymph node;right inguinal deep lymph node;right closed obturator upper lymph node;right closed obturator lymph node;right closed obturator lymph node;right closed obturator deep lymph node;Anterior lymph node;Abdominal aortic lymph node resection;abdominal aortic lymph node metastasis;abdominal aortic lymph node metastas

Countries

China

Contacts

Public ContactHao Min

The Second Hospital of Shanxi Medical University

2yuanhaomin@163.com+86 13934569668

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026